Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment — Stella

Home/Gynecologic Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Gynecologic Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(4 sites)

United States

NYP Brooklyn Methodist Hospital, Brooklyn, New York

NYP Lower Manhattan Hospital, New York, New York

Weill Cornell Medicine, New York, New York

NYP Medical Group Queens, Queens, New York

Key details

Sponsor

Weill Medical College of Cornell University

Enrollment target

~150 participants

Started

January 2023

Primary completion

December 2026

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.